Project Grant R43NS139780
Award Date
9/4/24
Completion Date
8/31/25
Dollars Obligated
$308K
Funding Federal Agency
National Institute on Aging
Awarding Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $472,695 to 3D Bioanalytix, Inc., a woman-owned small business in San Diego, CA, to develop a blood-based diagnostic test for the early detection of neurodegenerative diseases such as Alzheimer's. The award period runs from September 25, 2024 to August 31, 2025. The proposed test utilizes a novel Covalent Protein Painting (CPP) technology to detect and differentiate the misfolded protein...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $885,006 to Brigham & Women's Hospital Inc. to develop a smartphone-based point-of-care diagnostic system for detecting Alzheimer's disease-related biomarkers in blood plasma. The system will utilize microfluidics, nanotechnology, optical sensing, and deep learning to measure amyloid-beta, phosphorylated tau, and neurofilament light chain within 30 minutes, with the goal of creating an...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Neuroscope Inc. in the amount of $1,193,370 aims to develop a computational toolset for mapping and quantifying perivascular space (PVS) morphology from MRI. The goal is to create a non-invasive, automated method to assess PVS, which is an important diagnostic feature for Alzheimer's disease and vascular dementia. The funded work will build the IT infrastructure to commercialize Neuroscope's PVS...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to create an inter-Alzheimer's Disease Research Center (ADRC) set of objectively measured cerebral small vessel disease (SVD) magnetic resonance imaging (MRI) biomarkers from large and diverse clinical cohorts. The $790,491 award will fund the development and validation of novel deep-learning methods to accurately quantify SVD biomarkers, including cerebral microbleeds, white matter...
This $306,509 federal Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to Captis Diagnostics Inc. aims to develop a technology platform for rapid magnetic isolation of neuronal extracellular vesicles (EVs) from blood plasma samples. The goal is to enable the detection of biomarkers for neurological diseases such as Alzheimer's, Parkinson's, and traumatic brain injury through a minimally invasive liquid biopsy approach. Key activities include developing...
The University of Wisconsin - Madison received a $640,906 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to elucidate cerebrovascular disease pathways contributing to cognitive decline. The project aims to utilize advanced neuroimaging techniques to understand the interactions between cerebrovascular disease processes, Alzheimer's disease pathology, brain tissue injury, and cognitive function. By reprocessing existing longitudinal data from over 2,000...
This $834,094 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to advance research on post-stroke cognitive impairment and dementia (PSCID). The funding will support a multi-year effort leveraging a national stroke registry and Medicare data to determine the incidence and prevalence of PSCID, identify associated risk factors, and explore potential pharmacological prevention strategies. Key aspects of the research include a patient-centered approach,...
This $7,997,945 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to improve diagnosis of Alzheimer's disease and related dementias in primary care settings. The primary awardee, The Regents of the University of California, San Francisco, will implement a comprehensive diagnostic toolkit and expert case review process across five primary care practices in California that serve medically underserved communities. The project...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant awarded to Bioimaginix LLC, a for-profit small business, aims to develop a low-cost diagnostic tool for Alzheimer's disease (AD) and mild cognitive impairment (MCI) using artificial intelligence (AI) and machine learning (ML) algorithms applied to magnetic resonance imaging (MRI) brain scans. The $303,089 award will fund the creation of an AI-based platform that can distinguish AD from MCI...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) in the amount of $801,476 is focused on studying cerebrovascular reactivity (CVR) as a potential biomarker for vascular contributions to cognitive impairment and dementia (VCID) in patients with CADASIL, a rare genetic form of small vessel disease. The University of Wisconsin-Madison is the prime awardee and will leverage an existing longitudinal cohort of 400 CADASIL patients with NOTCH3 gene...